PMS-Montelukast: impurity
Last updated
Summary
Product
PMS-Montelukast
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
PMS-Montelukast |
PMS-Montelukast |
DIN 02354985 |
Tablet (to chew) |
Montelukast sodium 5mg |
637132 |
Issue
Presence of an unspecified impurity near the acceptable concentration limit in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Pharmascience Inc.
6111 ave Royalmount suite 100,
Montréal, QC
H4P 2T4
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-64184
Get notified
Receive notifications for new and updated recalls and alerts by category.